Advertisement

Topics

Sanofi SA Company Profile

09:37 EDT 22nd September 2017 | BioPortfolio

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales.

Location

174, av. de France
PARIS
New Jersey
75013
France


News Articles [582 Associated News Articles listed on BioPortfolio]

Sanofi-DuoRendite-Aktienanleihe Pro auf Sanofi mit 2,5% Zinsen

Sanofi-DuoRendite-Aktienanleihe Pro auf Sanofi mit 2,5% Zinse Die französische Sanofi (ISIN: FR0000120578) belegt mit über 100.000 Mitarbeitern in mehr als 100 Ländern und einem Umsatz von knapp 3....

Sanofi-Calls mit 146%-Chance bei Kursanstieg auf 85 EUR

Sanofi-Calls mit 146%-Chance bei Kursanstieg auf 85 EU Laut Analyse von www.godmode-trader.de überzeigten die Zahlen des Pharma Unternehmens Sanofi durchwegs. Dennoch konnte die Sanofi-Aktie (ISIN...

Sanofi finalise l’acquisition de Protein Sciences

Sanofi — Monday, August 28th 2017 at 5:00am UTC  Sanofi finalise l’acquisition de Protein Sciences – Un vaccin antigrippal quadrivalent innovantviendra compléter la gamme de vaccin...

Sanofi: le CHMP recommande l’approbation de l’insuline lispro biosimilaire de Sanofi

Sanofi — Friday, May 19th 2017 at 11:09am UTC Le CHMP recommande l’approbation de l’insuline lispro biosimilaire de Sanofi – Un avis favorable fondé sur les résultats du pro...

Sanofi: Sanofi rated AA by Scope Ratings

Sanofi rated AA by Scope Ratings Paris, France - September 7, 2017 - Sanofi (http://www.sanofi.com/) announced today that the European ratings agency Scope Ratings AG ("Scope") assigned the compan...

UK first EU market for Sanofi Pasteur quadrivalent flu vaccine

Sanofi Pasteur, the vaccines division of French pharma major Sanofi, announced today that, for the first…

Sanofi Pasteur inks antibody discovery accord for influenza vaccine research

Sanofi Pasteur, the vaccines business of French pharma major Sanofi, has entered into a collaborative…

Sanofi Completes Protein Sciences Buy

Following all regulatory approvals, French drugmaker Sanofi has completed the acquisition of Protein Sciences, a US vaccines biotech based in Meriden, Connecticut. The deal enhances the presence of Sa...

Drugs and Medications [50 Associated Drugs and Medications listed on BioPortfolio]

Nilandron [sanofi-aventis U.S. LLC]

NILANDRON (nilutamide)Tablets

Allegra d 12 hour allergy and congestion [Rebel Distributors Corp]

Allegra-D 12 Hour Allergy and Congestion

Allegra d 12 hour allergy and congestion [Chattem, Inc.]

Allegra-D 12 Hour Allergy and Congestion

Hiprex(methenamine hippurate tablets usp) [sanofi-aventis U.S. LLC]

HIPREX(methenamine hippurate tablets USP)

Taxotere [sanofi-aventis U.S. LLC]

These highlights do not include all the information needed to use TAXOTERE safely and effectively. See full prescribing information for TAXOTERE.  TAXOTERE (docetaxel) Injection Concentrate, Intraven...

PubMed Articles [9 Associated PubMed Articles listed on BioPortfolio]

Update: Temporary Total Depletion of U.S. Licensed Yellow Fever Vaccine for Civilian Travelers Addressed by Investigational New Drug Use of Imported Stamaril Vaccine.

Sanofi Pasteur, the manufacturer of the only yellow fever vaccine (YF-VAX) licensed in the United States, has announced that their stock of YF-VAX is totally depleted as of July 24, 2017. YF-VAX for c...

Addressing a Yellow Fever Vaccine Shortage - United States, 2016-2017.

Recent manufacturing problems resulted in a shortage of the only U.S.-licensed yellow fever vaccine. This shortage is expected to lead to a complete depletion of yellow fever vaccine available for the...

Safety and Efficacy of Ziv-Aflibercept in the Treatment of Refractory Diabetic Macular Edema.

To evaluate the safety and efficacy of ziv-aflibercept (Zaltrap; Sanofi-Aventis, Bridgewater, NJ/Regeneron Pharmaceuticals, Tarrytown, NY) in the treatment of refractory diabetic macular edema (DME).

Sofosbuvir as treatment against dengue?

Dengvaxia(®) (CTD-TDV), the only licensed tetravalent dengue vaccine by Sanofi Pasteur was made available since 2015. However, administration of CTD-TDV in general has not received the prequalificati...

G-protein based ELISA as a potency test for rabies vaccines.

The NIH test is currently used to assess the potency of rabies vaccine, a key criterion for vaccine release. This test is based on mice immunization followed by intracerebral viral challenge. As part ...

Clinical Trials [64 Associated Clinical Trials listed on BioPortfolio]

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Primary objectives: - To describe the immune response to each dengue serotype before and after each vaccination with sanofi pasteur's CYD dengue vaccine. - To evaluate t...

A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects

The purpose of this study is to determine bioequivalence of amodiaquine suspension ( Pfizer) and the WHO approved reference product Flavoquine® tablet ( Sanofi Aventis).

Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand

The present clinical study will assess the immunogenicity and reactogenicity of Sanofi Pasteur's DTacP-IPV// PRP~T combined vaccine (Pentavac™ or Pentaxim™) as a three-dose primary vac...

Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry

The Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry will be a prospectively recruited pregnancy surveillance program designed to collect and analyze information on v...

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

This trial will evaluate the use of a tetravalent vaccine against dengue. Primary objectives: - To describe the immune response to dengue before and after each vaccination with ...

Companies [58 Associated Companies listed on BioPortfolio]

sanofi-aventis U.S.

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the lives of patients. San...

Bristol-Myers Squibb & Sanofi-aventis

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the l...

Sanofi Aventis Groupe

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SA...

Sanofi Pharmaceuticals Incorporated

Sanofi Pharmaceuticals are the U.S. subsidiary of Sanofi-Synthelabo, the global healthcare company. With annual sales in excess of $5.6 billion and 30,000 employees in more than 100 countries, Sanofi-...

Sanofi Pasteur MSD AG

Sanofi Pasteur MSD is the only European company dedicated exclusively to vaccines and was founded in 1994, as a joint venture between Sanofi Pasteur and Merck and Co. Inc.Sanofi Pasteur MSD develops v...

More Information about "Sanofi SA" on BioPortfolio

We have published hundreds of Sanofi SA news stories on BioPortfolio along with dozens of Sanofi SA Clinical Trials and PubMed Articles about Sanofi SA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sanofi SA Companies in our database. You can also find out about relevant Sanofi SA Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record